Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a ...

Complete responses (CR/CRu) on a phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL). This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I.

Reston, VA – When developing a treatment plan for cervical cancer, it is important to be able to determine a patient's prognosis, ideally at the time of diagnosis. Existing methods to arrive at a ...

A characteristic feature of Alzheimer's disease may not be the most accurate measure of its severity and progression in patients, according to new research from the University of Pennsylvania and ...

SALT LAKE CITY – A PET scan (positron emission tomography) that measures uptake of sugar in the brain significantly improves the accuracy of diagnosing a type of dementia often mistaken for ...

FDG-PET/CT could be very helpful in calculating the risk of developing interval metastasis during neoadjuvant chemoradiotherapy for oesophageal cancer, and it could lead to other more appropriate ...

At first glance, it might appear that better access to so-called amyloid-PET scans could compensate for some of the racial inequities in Alzheimer’s disease, as Linda Goler Blount called for in a ...